Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02042898 · ClinicalTrials.gov registry record · NA
Transfusion Requirements in Cardiac Surgery III
A NA study, sponsored by Unity Health Toronto.
- Completed
- Registry status
- NA
- Development phase
- 5,028
- Enrollment target
NCT02042898 is a NA study that has completed, run by Unity Health Toronto. The registered enrollment target is 5,028 participants.
The verdict
NCT02042898, a NA study, has completed, sponsored by Unity Health Toronto.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,028 participants
- Enrollment target
Study Summary
TRICS-III is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in high risk patients having cardiac surgery using a non-inferiority trial design.
Interventions
- OTHER Restrictive Transfusion Strategy
- OTHER Liberal transfusion strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,028 participants |
| Start Date | 2014-01-20 |
| Est. Completion | 2017-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02042898
The ClinicalTrials.gov registry entry for NCT02042898 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,028 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Unity Health Toronto, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Restrictive Transfusion Strategy is the first listed.
NCT02042898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02042898 about?
NCT02042898 is a clinical study titled "Transfusion Requirements in Cardiac Surgery III". TRICS-III is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in high risk patients having cardiac surgery using a non-inferiority trial design.
What is the current status of trial NCT02042898?
This trial is currently completed. It is a NA study. The enrollment target is 5,028 participants. The study started on 2014-01-20. Estimated completion is 2017-10-01.
What interventions are being tested in trial NCT02042898?
The interventions under investigation include: Restrictive Transfusion Strategy (OTHER), Liberal transfusion strategy (OTHER).
Who is sponsoring clinical trial NCT02042898?
This trial is sponsored by Unity Health Toronto, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.